Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Bionor Pharma ApS
APS
In liquidation
CVR 36445564
Strandvejen 100, 2900
Hellerup
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2014 · 11 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
Bionor Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (4)
DH
David Horn Solomon
Management
Management
2015 – 2016
PA
Peter Andreas Stakemann
Management
Management
2014 – 2015
RM
Regina Møller Andersen
Unofficial title
Unofficial title
2016 – 2017
UH
Unni Hjelmaas
Chief Executive Officer
Chief Executive Officer
2016 – 2016
Board of directors
Non-executive oversight
Name
Role
Member since
Former (5)
GA
Gunnar Arne Flåten
Board of Directors
Board of Directors
2015 – 2016
TJ
Thomas Jeffrey Malherbes Gullacksen
Chairman
Chairman
2014 – 2015
SV
Søren Vitfell Keller
Board of Directors
Board of Directors
2015 – 2016
UL
Ulf Lund
Board of Directors
Board of Directors
2014 – 2015
PT
Per-Sveno Thoresen
Chairman
Chairman
2016 – 2016
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Bionor Pharma ASA
Individual
100%
100%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Bionor Pharma ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network